BP102 - BoYuan RunSheng Pharma
retlirafusp alfa (SHR-1701) - Jiangsu Hengrui Pharma
https://www.onclive.com/view/frontline-shr-1701-plus-bp102-and-chemo-shows-potent-activity-in-cervical-cancer
 
Jul 18, 2023
 
Next